Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006
published in: Journal of Clinical Oncology
date of publication: 2013-04-08
language: English
main subject: multicenter clinical trial, chemotherapy, overexpression, breast cancer, trastuzumab
Cites articles 47
- 2011-02-22
Date
Title
Article - wd:Q36810717